Residency · Residency · Dermatology
Chronic Leg Ulcers: Venous, Arterial, and Neuropathic
Introduction
Chronic leg ulcers affect approximately 1 to 2% of the adult population and impose an enormous burden on patients and healthcare systems. Accurate identification of the underlying etiology -- venous, arterial, neuropathic, or mixed -- is critical because management strategies differ fundamentally. A systematic approach to assessment prevents treatment failures and avoids potentially harmful interventions.
Venous Leg Ulcers
Pathophysiology
Venous leg ulcers result from venous hypertension caused by valvular incompetence (reflux) and/or venous obstruction (post-thrombotic syndrome). Sustained ambulatory venous pressure leads to capillary distension, fibrin cuff deposition, leukocyte trapping, and tissue hypoxia. The trap hypothesis proposes that macromolecules leak into the pericapillary space, trapping growth factors and reducing their bioavailability for wound healing.
Clinical Features
Venous ulcers are classically located over the medial malleolus (gaiter area). The wound is typically shallow with irregular borders, a granulating base, and moderate exudate. Surrounding skin changes collectively termed lipodermatosclerosis include hemosiderin deposition (brown pigmentation), stasis dermatitis (eczematous change), atrophie blanche (white scarring with telangiectasias), and an inverted champagne bottle deformity of the lower leg. Varicose veins and leg edema are frequently present. Venous ulcers are usually not significantly painful unless complicated by infection or contact dermatitis.
Diagnosis
The ankle-brachial pressure index (ABPI/ABI) must be measured before initiating compression; an ABPI greater than 0.8 confirms predominantly venous etiology and establishes the safety of compression. Duplex ultrasonography identifies reflux, obstruction, and maps venous anatomy. Biopsy should be considered if the ulcer fails to heal after 3 months of appropriate therapy, to exclude malignancy (Marjolin ulcer), vasculitis, or pyoderma gangrenosum.
Management
Compression therapy is the cornerstone of treatment. Sustained graduated compression (30 to 40 mmHg) promotes venous return and reduces edema. Multi-layer bandaging is preferred for active ulcers (for example, a four-layer bandage system), while compression stockings (class II, 30 to 40 mmHg) maintain healing and prevent recurrence. Compression is contraindicated if ABPI is below 0.5, and modified reduced compression should be used with caution for ABPI between 0.5 and 0.8. Wound care should maintain a moist wound healing environment with appropriate dressings (foam, alginate, hydrofiber) selected based on exudate level. Stasis dermatitis is treated with mid-potency topical corticosteroids, avoiding common contact allergens (lanolin, neomycin, rubber accelerators in bandages). Pentoxifylline 400 mg three times daily is an adjunctive agent that improves healing by enhancing microcirculatory flow. Surgical or interventional approaches including venous ablation, sclerotherapy, or stenting address correctable reflux or obstruction. Skin grafting with split-thickness skin grafts or bioengineered skin substitutes is considered for refractory ulcers.
<image>Clinical photograph of a classic venous leg ulcer over the medial malleolus with surrounding lipodermatosclerosis, hemosiderin staining, and atrophie blanche, alongside a cross-sectional diagram showing venous valve incompetence and resulting ambulatory venous hypertension</image>
Arterial Ulcers
Pathophysiology
Arterial ulcers result from peripheral arterial disease (PAD) in which atherosclerosis of the lower limb arteries reduces perfusion pressure. Tissue ischemia leads to necrosis, particularly at sites farthest from the heart or most susceptible to pressure.
Clinical Features
Arterial ulcers are located on the toes, dorsal foot, lateral malleolus, pretibial area, and pressure points. The wound is characteristically punched-out with well-defined borders, a pale or necrotic base, minimal exudate, and may have eschar. Surrounding skin is shiny, atrophic, hairless, and cool, with pallor on elevation and dependent rubor. Pain is significant, especially at rest or with leg elevation, and is often worse at night. Absent or diminished pedal pulses are a hallmark finding.
Diagnosis
An ABPI below 0.9 indicates PAD, while below 0.5 indicates critical limb ischemia. Caution is needed because ABPI may be falsely elevated (above 1.3) in diabetic patients due to medial arterial calcification (Monckeberg sclerosis). The toe-brachial index (TBI) is more reliable in diabetics, with below 0.7 considered abnormal. CT angiography or catheter angiography is obtained for surgical planning.
Management
Vascular surgery referral is paramount, as revascularization (bypass or endovascular) is the definitive treatment. Compression must NOT be applied to purely arterial ulcers because this worsens ischemia. Wound care should maintain a moist environment, but stable eschar should not be debrided in non-revascularizable limbs (dry gangrene). Cardiovascular risk reduction through smoking cessation, antiplatelet therapy, statin therapy, and blood pressure and glucose control is essential. Pain management is critical and may require opioids in critical limb ischemia. Amputation may be necessary for non-revascularizable critical ischemia with progressive gangrene.
Neuropathic Ulcers
Pathophysiology
Peripheral neuropathy, most commonly from diabetes mellitus, leads to loss of protective sensation. Repeated unrecognized mechanical trauma occurs at pressure points. Autonomic neuropathy causes anhidrosis and fissuring, while motor neuropathy causes foot deformity (claw toes, Charcot joint).
Clinical Features
Neuropathic ulcers are located on the plantar surface of the foot over metatarsal heads, the heel, and other pressure points (malperforans ulcer). The wound is characteristically punched-out, surrounded by callus (hyperkeratotic rim), painless, and often deep with sinus tract formation. The patient is frequently unaware of the ulcer. Charcot neuroarthropathy is a destructive joint disease presenting with a warm, swollen, deformed foot that is commonly misdiagnosed as cellulitis or DVT.
Diagnosis
Semmes-Weinstein monofilament testing demonstrates neuropathy when the patient cannot perceive the 10 g monofilament. Vibration testing with a 128 Hz tuning fork shows reduced vibratory perception. X-ray evaluates for osteomyelitis, and the probe-to-bone test (where bone palpable through the ulcer carries a positive predictive value of approximately 89% for osteomyelitis) is a valuable bedside assessment. MRI is the gold standard for osteomyelitis detection.
Management
Offloading is the single most important intervention. Total contact casting (TCC) is the gold standard, reducing plantar pressure by 60 to 80%. Debridement with regular sharp debridement of callus and necrotic tissue promotes healing. Infection control is critical because diabetic foot infections require aggressive antibiotic therapy and are often polymicrobial (gram-positive cocci, gram-negatives, anaerobes). Glycemic control with HbA1c optimization improves wound healing. A multidisciplinary diabetic foot team involving endocrinology, vascular surgery, podiatry, and wound care nursing provides the best outcomes.
<image>Comparison diagram of three major chronic leg ulcer types: venous (medial malleolus, shallow, with stasis changes), arterial (distal/lateral, punched-out, with pale base), and neuropathic (plantar, surrounded by callus, painless) with key differentiating clinical and diagnostic features listed</image>
| Feature | Venous Ulcer | Arterial Ulcer | Neuropathic Ulcer |
|---|---|---|---|
| Location | Medial malleolus (gaiter area) | Toes, dorsal foot, lateral malleolus | Plantar surface, metatarsal heads |
| Morphology | Shallow, irregular borders, granulating | Punched-out, pale/necrotic base, eschar | Punched-out, surrounded by callus |
| Pain | Minimal (unless infected) | Significant; worse at night/elevation | Painless |
| Surrounding skin | Hemosiderin, lipodermatosclerosis, atrophie blanche | Shiny, atrophic, hairless, cool | Dry, fissured, deformed foot |
| Pulses | Present | Diminished/absent | Usually present |
| ABPI | >0.8 | <0.9 (<0.5 = critical) | May be falsely elevated (calcification) |
| Key treatment | Compression therapy | Revascularization | Offloading (total contact cast) |
| Contraindication | Compression if ABPI <0.5 | Compression | Weight-bearing without offloading |
Mixed and Atypical Ulcers
Mixed Venous-Arterial
Combined venous insufficiency and peripheral arterial disease is common in elderly patients. When the ABPI is 0.5 to 0.8, modified compression (reduced pressure, 20 to 25 mmHg) can be used with close monitoring. When the ABPI is below 0.5, compression is contraindicated and vascular assessment takes priority.
Atypical Ulcers Requiring Biopsy
Several atypical ulcers warrant tissue sampling. Marjolin ulcer is SCC arising in a chronic wound or scar. Pyoderma gangrenosum presents as a rapidly expanding ulcer with undermined violaceous borders and pathergy phenomenon. Vasculitic ulcers feature palpable purpura, livedo reticularis, and systemic symptoms. Calciphylaxis causes exquisitely painful necrotic ulcers with retiform purpura, prompting evaluation of calcium, phosphorus, and PTH. Factitial ulcers have bizarre shapes, linear borders, and are found in accessible locations.
Key Clinical Pearls
ABPI must always be measured before applying compression, because compression on an arterial ulcer can precipitate critical ischemia. Venous ulcers that fail to improve after 3 months of compression therapy should be biopsied to exclude malignancy. Neuropathic ulcers require offloading as the primary intervention, with total contact casting as the gold standard. Contact dermatitis to wound dressings and topical agents is common in chronic venous ulcer patients, and patch testing should be performed if stasis dermatitis worsens. The probe-to-bone test has high positive predictive value for osteomyelitis in diabetic foot ulcers.
References
- O'Meara S, Cullum N, Nelson EA, Dumville JC. Compression for venous leg ulcers. Cochrane Database Syst Rev. 2012;11:CD000265.
- Alavi A, Sibbald RG, Phillips TJ, et al. What's new: management of venous leg ulcers. J Am Acad Dermatol. 2016;74(4):627-640.
- Lipsky BA, Berendt AR, Cornia PB, et al. 2012 IDSA clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-e173.
- Mosti G. Compression in mixed ulcers: venous side. Phlebology. 2014;29(1 Suppl):13-17.
